about
Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkersRole of Galectin-3 in Obesity and Impaired Glucose HomeostasisNuclear transport of galectin-3 and its therapeutic implicationsGalectins in epithelial functionsGalectin-3: its role in asthma and potential as an anti-inflammatory targetThe roles of Galectin-3 in autoimmunity and tumor progressionProteome serological determination of tumor-associated antigens in melanoma.Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma.Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activitySoy and breast cancer: focus on angiogenesis.The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.MicroRNA-424 Predicts a Role for β-1,4 Branched Glycosylation in Cell Cycle Progression.Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles.Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression.Galectin-3 and the skinMolecular biology of adenoid cystic carcinomaHierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis.Galectin-3: an emerging all-out player in metabolic disorders and their complications.Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference.Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.Cleavage and phosphorylation: important post-translational modifications of galectin-3.Galectin-1 and Galectin-3 Mediate Protocadherin-24-Dependent Membrane Localization of β-catenin in Colon Cancer Cell Line HCT116Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-cateninGalectin-3: A novel substrate for c-Abl kinase.Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma.Effects of TPX2 gene on radiotherapy sensitization in breast cancer stem cells.The inactive form of glycogen synthase kinase-3β is associated with the development of carcinomas in galectin-3 wild-type mice, but not in galectin-3-deficient mice.Expression of APC protein during tongue malignant transformation in galectin-3-deficient mice challenged by the carcinogen 4-nitroquniline-n-oxide.Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice.Galectin-3 induced by hypoxia promotes cell migration in thyroid cancer cells.The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.Role of MSC-derived galectin 3 in the AML microenvironment.Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
P2860
Q21134996-F63634AE-05CE-4CA6-8AB1-4C466361CB82Q26771826-4A7DB562-7FC4-4907-B9AD-AAD806AFB3EAQ26824889-4705264B-DBF4-42A9-8AD2-C7F1FD01D093Q27000800-9541419A-E5AB-417E-A989-0BE675B1FB08Q27023534-19AA0260-CA70-4DDA-A65A-9E749825B149Q28261890-068AAC5A-A53C-4845-8903-00243C8D7548Q33432732-826EEEAF-A236-4162-9B58-0138FC6B5802Q33899239-8E610F92-F3D0-492F-9383-F530EB20A2A8Q34343335-F0DA741A-66E0-4DDD-B736-B8EF3A630083Q34477740-9B9E8F0D-3584-46AC-8AAA-A1CC9E2B87BCQ34581026-0C20F93F-E8EB-47E7-8DAC-B1F15181999BQ36405959-D5F9AC2A-4418-4BFA-905F-1101DBF0C296Q36466243-CF35127D-E909-4F8C-B3B0-A4AD22EE1C59Q36601648-F54E449D-50FF-4388-941F-6D36988B7805Q37322616-8B7AC071-BCB7-4E06-A66F-4B8CD8C639ECQ37716533-EC49D56E-4DBF-4A19-BDD8-45AE13996541Q37926145-62CB5A21-94BC-4C06-82E7-9B999906D096Q37946780-6B158BA7-2037-4CB5-9FAF-E8DBA9EDDC0AQ38174863-50BF3C44-6A19-480C-8D22-9E4304853824Q38232998-89BD7A80-0653-4083-9085-91AD98C8FBD4Q38258947-0DB45464-07E9-42B3-A3E0-B20FD8C6E222Q38315100-4078D8E9-0C2D-4044-A463-347E29DA796EQ38721483-30B521FD-FC6C-4705-8342-CF5347B2DE33Q38909319-48311BFC-2561-472F-B1A6-8918C4E360B9Q38932655-297DEB77-CC59-4D08-B223-0E2AC0924808Q39220862-5F6F401E-9953-42D0-829B-D047BA8254CEQ39250900-CE9DC974-AE20-48E0-836B-52AD583618DFQ39252635-06F62DFB-B73D-47BF-8085-13B21899A293Q39684862-50294076-AE08-4F3C-9401-6CB85DF793D1Q40979079-8724CB21-228A-474B-A421-62048DEB6005Q41142259-3EBA3E96-A191-4377-9659-93CDC003A0DBQ42321776-6B857C08-5404-47DB-9A5E-8354CC62FBD8Q42735222-336D4C75-A7FC-4514-BFED-B2FCFDF0DD35Q46320321-C33B8C2E-B5E8-4CB9-BA5E-1192E9629D3FQ47100465-80B5F7BD-CD2E-4B52-9301-2635841B7A6FQ47703344-12D69F77-52A8-4A53-BC91-94167B2CDBBCQ48270428-E8DAA8CC-F9F8-4F20-8888-A7AE0A3D857CQ52588202-FDCB1AD7-B12F-416F-A9B1-7157D60AC9A0Q57491296-59D31EFB-19A3-4EF0-B706-21AE50F2C7F2
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Implication of galectin-3 in Wnt signaling.
@en
type
label
Implication of galectin-3 in Wnt signaling.
@en
prefLabel
Implication of galectin-3 in Wnt signaling.
@en
P2093
P1433
P1476
Implication of galectin-3 in Wnt signaling
@en
P2093
Akira Kikuchi
Avraham Raz
Hiroyuki Kuwano
Kohji Okada
Soichi Tsutsumi
Tatsuo Shimura
Tomoharu Fukumori
Victor Hogan
P304
P356
10.1158/0008-5472.CAN-05-0104
P407
P577
2005-05-01T00:00:00Z